Home
>
National Drug Code (NDC)
>
Dacarbazine
Dacarbazine - 61703-327-22 - (DACARBAZINE)
Drug Information of Dacarbazine
| Product NDC: | 61703-327 |
| Proprietary Name: | Dacarbazine |
| Non Proprietary Name: | DACARBAZINE |
| Active Ingredient(s): | 200 mg/1 & nbsp; DACARBAZINE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dacarbazine
| Product NDC: | 61703-327 |
| Labeler Name: | Hospira Worldwide, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075940 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110923 |
Package Information of Dacarbazine
| Package NDC: | 61703-327-22 |
| Package Description: | 1 VIAL in 1 CARTON (61703-327-22) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Information of Dacarbazine
| NDC Code | 61703-327-22 |
| Proprietary Name | Dacarbazine |
| Package Description | 1 VIAL in 1 CARTON (61703-327-22) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
| Product NDC | 61703-327 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DACARBAZINE |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110923 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira Worldwide, Inc. |
| Substance Name | DACARBAZINE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
